Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Saturday, April 1, 2023.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Bull Market Weakness (+75) - NBIX is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on NBIX as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid NBIX?
MarketClub looks at technical strength and momentum to determine if the timing is right for NBIX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for NBIX
The long-term trend has been DOWN since Feb 2nd, 2023 at 106.22
The intermediate-term trend has been UP since Mar 31st, 2023 at 101.35
The short-term trend has been UP since Mar 20th, 2023 at 95.62
Smart Scan Analysis for NBIX
Based on our trend formula, NBIX is rated as a +70 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 99.45 | 101.53 | 98.62 | 101.25 | +2.04 |
| Prev. Close | Volume | Bid | Ask | Time |
| 101.22 | 746003 | 2023-03-31 15:59:14 |
| Year High | 126.98 | Year High Date | 2018-09-13 |
| Year Low | 74.12 | Year Low Date | 2018-01-17 |
| 52wk High | 129.29 | 52wk High Date | 2022-12-01 |
| 52wk Low | 75.25 | 52wk Low Date | 2022-05-09 |
| Year End Close | 7.48 | Average Volume | 682,309 |
| Shares Outstanding | 96,588 | Short Interest | 2,757,358 |
| % Institutional | 82.1 | Market Cap | 8,737M |
| Assets | 236,870,000M | Liabilities | 660,900,000M |
| P/E Ratio | 63.5962 | Beta | 0.3 |
| Volatility | 65.12 |